Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer

被引：0
|
作者：
Maruyama, Kohei [1 ,2 ]
Suzuki, Mai [1 ,2 ]
Ohhara, Tomoko [1 ]
Nagayama, Satoshi [3 ]
Fujita, Naoya [4 ]
Katayama, Ryohei [1 ,2 ]
机构：
[1] JFCR, Div Exp Chemother, Canc Chemother Ctr, Tokyo, Japan
[2] Univ Tokyo, Dept CBMS, Grad Sch Front Sci, Tokyo, Japan
[3] JFCR, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan
[4] JFCR, Canc Chemother Ctr, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-2032
引用
收藏
页码：783 / 783
页数：1
相关论文
共 50 条
  • [41] Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
    Xu, Ke
    Park, Dongkyoo
    Magis, Andrew T.
    Zhang, Jun
    Zhou, Wei
    Sica, Gabriel L.
    Ramalingam, Suresh S.
    Curran, Walter J.
    Deng, Xingming
    MOLECULAR CANCER, 2019, 18 (1)
  • [42] KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
    Ambrogio, Chiara
    Kohler, Jens
    Zhou, Zhi-Wei
    Wang, Haiyun
    Paranal, Raymond
    Li, Jiaqi
    Capelletti, Marzia
    Caffarra, Cristina
    Li, Shuai
    Lv, Qi
    Gondi, Sudershan
    Hunter, John C.
    Lu, Jia
    Chiarle, Roberto
    Santamaria, David
    Westover, Kenneth D.
    Janne, Pasi A.
    CELL, 2018, 172 (04) : 857 - +
  • [43] Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
    Dilly, Julien
    Hoffman, Megan T.
    Abbassi, Laleh
    Li, Ziyue
    Paradiso, Francesca
    Parent, Brendan D.
    Hennessey, Connor J.
    Jordan, Alexander C.
    Morgado, Micaela
    Dasgupta, Shatavisha
    Uribe, Giselle A.
    Yang, Annan
    Kapner, Kevin S.
    Hambitzer, Felix P.
    Qiang, Li
    Feng, Hanrong
    Geisberg, Jacob
    Wang, Junning
    Evans, Kyle E.
    Lyu, Hengyu
    Schalck, Aislyn
    Feng, Ningping
    Lopez, Anastasia M.
    Bristow, Christopher A.
    Kim, Michael P.
    Rajapakshe, Kimal I.
    Bahrambeigi, Vahid
    Roth, Jennifer A.
    Garg, Kavita
    Guerrero, Paola A.
    Stanger, Ben Z.
    Cristea, Simona
    Lowe, Scott W.
    Baslan, Timour
    Van Allen, Eliezer M.
    Mancias, Joseph D.
    Chan, Emily
    Anderson, Abraham
    Katlinskaya, Yuliya V.
    Shalek, Alex K.
    Hong, David S.
    Pant, Shubham
    Hallin, Jill
    Anderes, Kenna
    Olson, Peter
    Heffernan, Timothy P.
    Chugh, Seema
    Christensen, James G.
    Maitra, Anirban
    Wolpin, Brian M.
    CANCER DISCOVERY, 2024, 14 (11) : 2135 - 2161
  • [44] KRAS mutant-specific interactions reveal mechanisms in pancreatic cancer tumorigenesis and metabolic function
    Sundararaj, Kamala
    Burge, Rachel
    Saberikashani, Samaneh
    Bialousow, Lucas
    Linke, Amanda
    Smith, Merissa
    Ostrowski, Michael C.
    O'Bryan, John P.
    Hobbs, G. Aaron
    CANCER RESEARCH, 2024, 84 (02)
  • [45] Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cells
    Rouhi, Arefeh
    Miller, Christina
    Grasedieck, Sarah
    Reinhart, Stefanie
    Stolze, Britta
    Doehner, Hartmut
    Kuchenbauer, Florian
    Bullinger, Lars
    Froehling, Stefan
    Scholl, Claudia
    ONCOTARGET, 2017, 8 (05): : 7678 - 7690
  • [46] Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer
    Hiraki, Masayuki
    Nishimura, Junichi
    Takahashi, Hidekazu
    Wu, Xin
    Takahashi, Yusuke
    Miyo, Masaaki
    Nishida, Naohiro
    Uemura, Mamoru
    Hata, Taishi
    Takemasa, Ichiro
    Mizushima, Tsunekazu
    Soh, Jae-Won
    Doki, Yuichiro
    Mori, Masaki
    Yamamoto, Hirofumi
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2015, 4 : e231
  • [47] The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers
    Tria, Simon Manuel
    Burge, Matthew E.
    Whitehall, Vicki L. J.
    CANCERS, 2023, 15 (08)
  • [48] Molecular mechanisms of the combination treatment of cetuximab and dasatinib in Kras mutant colorectal tumors
    Dunn, E. F.
    Iida, M.
    Myers, R. A.
    Li, C.
    Wheeler, D. L.
    EJC SUPPLEMENTS, 2010, 8 (07): : 59 - 59
  • [49] Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer
    Jiffry, Jeeshan
    Thavornwatanayong, Thongthai
    Rao, Devika
    Fogel, Elisha J.
    Saytoo, Durvanand
    Nahata, Rishika
    Guzik, Hillary
    Chaudhary, Imran
    Augustine, Titto
    Goel, Sanjay
    Maitra, Radhashree
    CLINICAL CANCER RESEARCH, 2021, 27 (03) : 865 - 876
  • [50] Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer
    Maitra, Radhashree
    Augustine, Titto
    Coffey, Matt
    Goel, Sanjay
    CANCER RESEARCH, 2016, 76
12345